Results 321 to 330 of about 1,710,556 (364)

Regulation Policy on Cell- and Tissue-Based Therapy Products in Korea

Tissue Engineering Part A, 2015
Extensive investment on research and development of cell therapy products (CTPs) and tissue-engineered products (TEPs) has been made in Korea, and various commercial products are born in market. The Ministry of Food and Drug Safety (MFDS) in Korea regulates CTPs and TEPs as biological products under the authority of the Pharmaceutical Affairs Act.
Jeong-Ok Lim
openaire   +3 more sources

Polymerization‐Mediated Multifunctionalization of Living Cells for Enhanced Cell‐Based Therapy

Advances in Materials, 2021
Surface decoration of living cells by exogenous substances offers a unique tool for understanding and tuning cell behaviors, which plays a critical role in cell‐based therapy.
Chao Pan, Juanjuan Li, Weiliang Hou, Sisi Lin, Lu Wang, Yan Pang, Yufeng Wang, Jinyao Liu   +7 more
semanticscholar   +1 more source

Regenerative Cell and Tissue-based Therapies for Pulmonary Arterial Hypertension

Canadian Journal of Cardiology, 2014
Within the span of 2 decades, cell-based regenerative therapies for pulmonary arterial hypertension have progressed from bench-side hypotheses to clinical realities. Promising preclinical investigations that examined the therapeutic potential of endothelial progenitor cell and mesenchymal stem cell populations have demonstrated the safety and efficacy ...
William S, Foster, Colin M, Suen, Duncan J, Stewart   +2 more
openaire   +2 more sources

Importance of repeat tissue biopsy and tissue-based epidermal growth factor receptor T790M testing in progressed nonsmall cell lung carcinoma patients upon negative plasma genotyping for selection of third-generation tyrosine kinase inhibitor therapy: A case study

Indian Journal of Cancer, 2017
Resistance to 1st or 2nd generation epidermal growth factor receptor (EGFR) - tyrosine kinases (TKIs) develops predominantly due to an acquired mutation, EGFR T790M. Third-generation EGFR-TKIs have demonstrated potent activity against TKI resistance mediated by EGFR T790M.
R, Mistry, A, Patil
openaire   +2 more sources